While influenza viruses exhibit species-specific determinants, sporadically, they cross the species barrier, rapidly adapt to a new host, and establish new lineages. Despite early reports showing the presence of antibodies against human influenza viruses in dogs [1, 2] , there were no documented reports of canine influenza virus (CIV) infections until 2004, when the first CIV was identified in racing greyhound dogs in Florida [3] . Molecular and antigenic analyses revealed that all genes of the A(H3N8) virus isolated from infected dogs were closely related to equine influenza viruses [3] . The A(H3N8) virus spread to dogs in other states and continues to show limited circulation in the United States, especially among dogs housed in humane shelters [4] .
The first evidence of A(H3N2) CIV in domestic dogs displaying respiratory symptoms occurred in South Korea in 2007. Unlike the A(H3N8) virus, all genes of the A(H3N2) CIV showed >95.5% nucleotide identity with Eurasian lineage avian influenza A viruses (IAVs) circulating in wild and domestic birds [5] . The virus spread widely among dogs in South Korea, parts of China, and Thailand. In April 2015, an A(H3N2) virus that was genetically similar to CIVs circulating in Asia was isolated from an infected golden retriever in Cook County, Illinois. According to the updates posted by Animal Health Diagnostic Center, Cornell University College of Veterinary Medicine, the virus has since spread to multiple states, causing respiratory disease in thousands of dogs across the United States [51] .
Besides the 2 major subtypes of CIV, A(H3N8) and A(H3N2), other IAVs, including 2009 pandemic A(H1N1) [6, 7] , A(H5N1) [8] , A(H5N2) [9] , and A(H9N2) [10] , have been isolated from dogs. Further evidence that dogs can be infected with human influenza viruses comes from serological analyses [11, 12] , as well as experimental infections [13, 14] . Influenza viruses have a segmented genome, which allows for reassortment in coinfected hosts and emergence of novel influenza virus strains. Since dogs are close human companions, the notion that new strains could arise in dogs is concerning from a public health standpoint. No human infections have been reported with CIVs to date; nonetheless, continuous surveillance and assessment of the antigenic and pathobiological features of novel viruses is important to minimize and mitigate the possibility of zoonotic infections. Pigs are susceptible to IAVs from a variety of different hosts and pose a risk of interspecies transmission of new reassortant viruses. A recent study showed that the A(H3N2) CIV, newly isolated in the United States, displayed limited replication in the lower respiratory tract of inoculated swine and was not transmitted to contact pigs [15] . Here, we analyzed the genetic, antigenic, and structural features of A(H3N2) CIVs isolated in the United States. Furthermore, in vitro replication in a human airway epithelial cell line (Calu-3), pathogenesis in mice and ferrets, and transmissibility in ferrets were assessed.
MATERIALS AND METHODS

Viruses
The A(H3N2) viruses A/canine/IL/12191/2015 and A/ Switzerland/9715293/2013 were propagated in eggs at 35°C for 48 hours. A/Brisbane/59/2007 (H1N1) was propagated in Madin-Darby canine kidney cells at 37°C for 48 hours. Details are included in the Supplementary Information.
Molecular and Phylogenetic Analysis
A/canine/IL/12191/2015 virus RNA was reverse transcribed with random hexamer primers and amplified by PCR using universal IAV primers [16] . Full-length open reading frames (ORFs) were generated by Illumina sequencing. Consensus sequences were assembled and BLAST analysis of each gene was performed in the GISAID database to identify the closest related viruses. Gene sequences of related viruses were aligned to A/canine/IL/12191/2015 virus sequences, using MUSCLE to create full-length ORF alignments. The full-length ORF sequences of A/canine/IL/11613/2015 virus were generated by Cornell University (kindly provided by Dr Amy Glaser) and included in phylogenetic analysis. Alignments were imported into MEGA 5.0, and phylogenetic trees were generated using the generalized time reversible model and maximum likelihood method with 1000 bootstrap replicates. Hemagglutinin (HA) protein sequence alignments included human A(H3N2) viruses for comparisons of the A(H3N2) CIV receptor-binding and putative antigenic sites.
Determination of HA and Neuraminidase (NA) Structures and Glycan
Array Analyses
A/canine/IL/11613/2015 virus recombinant HA and NA crystallization, glycan microarray printing and recombinant HA (recHA) analyses have been described elsewhere [17, 18] . Details are included in Supplementary Information. Supplementary Table 2 lists glycans used in these experiments as well as a tabulated qualitative assessment of binding for each protein analyzed.
Antigenic Characterization
Virus-specific polyclonal antiserum against A/canine/ IL/12191/2015 virus was generated in serologically naive ferrets immunized intranasally with 10 6.0 50% egg infectious doses (EID 50 ) of virus diluted in PBS. At 14 days post-inoculation, each ferret was boosted with 2048 HAU of virus mixed with Titermax Gold Adjuvant (Sigma-Aldrich, St. Louis, MO) and antiserum was collected 14 days post-boost. A/canine/ IL/12191/2015 virus was compared by hemagglutination inhibition (HI) assay to panels of antiserum against other A(H3N2) IAVs and corresponding reference viruses [19] . Human immune serum, pooled from adults (19-49 years old) who received an inactivated 2013-2014 seasonal influenza vaccine, was included in the analysis. The human sera were acquired through a contract and received as anonymous samples, and, thus, were exempt from review by the Centers for Disease Control and Prevention's (CDC) Institutional Review Board.
Animal Experiments
Pathogenicity in mice and ferrets, and transmission efficiency between cohoused ferrets were evaluated as described elsewhere [20, 21] . Details are included in Supplementary Information.
Cell Culture and Viral Replication
Human airway epithelial Calu-3 cells, obtained from American Type Culture Collection (ATCC; Manassas, VA), were cultured on 12-mm transwell inserts as described previously [22] . Briefly, Calu-3 cells grown on transwells were inoculated apically in triplicate with A/canine/IL/12191/2015 (H3N2) virus, A/ Brisbane/59/2007 (H1N1) virus, or A/Switzerland/9715293/13 (H3N2) virus at a multiplicity of infection of 0.01 50% EID 50 / cell for 1 hour, washed, and then incubated at 37°C in a 5% CO 2 atmosphere. Viral titers in cell culture supernatant were determined by titration in eggs.
RESULTS
Phylogenetic and Genetic Characterization
Phylogenetic analysis of A/canine/IL/12191/2015 and A/ canine/IL/11613/2015 virus genes showed that these viruses were closely related to A(H3N2) CIVs isolated in South Korea in 2011-2012 ( Figure 1 and Supplementary Figures 1-7 ) and clustered in a larger group containing isolates from China and Thailand. While the US isolates of A(H3N2) CIVs showed 95% nucleotide identity to the duck A(H3N2) viruses, each gene segment of the US CIVs had >99% nucleotide identity to recently isolated South Korean CIVs, suggesting that the virus was recently transmitted between South Korean and US dogs.
The NA gene segment of US CIVs had amino acid deletions at positions 76 and 77 that were also observed in many related CIVs from South Korea and China and did not possess any known markers of resistance to NA inhibitors. The matrix 2 protein contained 2 mutations (Asn30Asp and Thr215Ala) associated with increased virulence of avian IAVs in mice but no molecular markers associated with resistance to adamantane. The PB2, PB1-F2, and NS proteins each had mutations at positions previously reported to enhance polymerase activity, infectivity, and increased virulence of H5N1 avian IAVs in mice [23] . The PA and NP proteins did not have mutations of known significance.
HA Structure
The 3-dimensional HA structure of the trimeric ectodomain from A/canine/IL/11613/2015 virus HA was determined by X-ray crystallography at a 3.0-Å resolution (Supplementary Table 1 ). Seven asparagine-linked glycosylation sites (NXS/T) were predicted in the CIV HA monomer; however, no interpretable carbohydrate electron density was observed at any location ( Figure 2A and Ile335Leu differences were identified near antigenic site D and in the HA2 portion of the protein, respectively (Figure 2A ). The CIV HA was produced in the HA0 form, using a baculovirus expression system. For structural studies, the HA was digested with trypsin to remove the trimerization tag, which also cut the HA into the active HA1/HA2 form. Comparison of the CIV HA monomer to an avian H3 HA (PDB: 1MQL) [24] and a recent human H3 HA (PDB: 4WE8) [25] revealed a highly similar structure, with the Cα atoms superimposing to give a root mean square deviation of 0.94 Å and 1.03 Å, respectively.
Receptor-Binding Site Analysis
Similar to other IAVs, the consensus receptor-binding site (RBS) was composed of three structural elements: a 190-helix (residues 188-94), 220-loop (residues 220-8), and 130-loop (residues 131-9). Highly conserved residues Tyr98, Trp153, His183, and Tyr195 were identified at the base of the pocket ( Figure 2B ). The HA sequences from A/canine/IL/12191/2015 and A/canine/IL/11613/2015 viruses primarily retained amino acids conserved among Eurasian lineage low-pathogenicity avian H3N2 IAVs. Amino acids in and around the RBS were typical of avian-origin IAVs, with signature Gln226 and Gly228 Conserved residues are shown in green sticks. The amino acids discussed in the text are labeled and shown in sticks. C, Glycans on the microarray are grouped according to sialic acid linkage, as follows: α2-3 SA, blue; α2-6 SA, red; α2-6/ α2-3 mixed SA, purple; N-glycolyl SA, green; α2-8 SA, brown; β2-6 and 9-O-acetyl SA, yellow; and asialoglycans, gray (Supplementary Table 2 ). Error bars reflect the standard error in the signal for 6 independent replicates on the array.
suggesting preferential binding to avian-like α2,3-linked sialic acid (SA) receptors. The HA proteins had a single mutation of Ser159Asn, which is an adaptation potentially resulting in increased binding to α2,6-linked SA receptors. This mutation was found in the majority of A(H3N2) CIVs in the databases. Similar to viruses detected in eastern Asia, the US CIVs had a Leu at position 222, differentiating them from avian H3 IAVs, which typically have a highly conserved Trp at this position. Interestingly, Leu at position 222 was also shared among A(H3N8) CIVs circulating in the United States, suggesting its potential role in adaptation of these viruses to dogs [26] [27] [28] . Glycan-binding analyses of recombinant CIV HA revealed a strong binding preference for the α2-3-linked SAs and mixed α2-3/α2-6 branched SAs (numbers 65 and 66). It also showed a relatively strong binding to N-glycolylneuraminic acid-containing glycans (number 71; Figure 2C and Supplementary Table 2 ).
NA Structure
The crystal structure was determined to a 1.8-Å resolution (Supplementary Table 1) , with good electron density for most of the residues, except the 150-loop area. The virus strain used for recombinant NA studies, A/canine/IL/11613/2015, had an NA identical to that of A/canine/IL/12191/2015 virus. The CIV NA structure was a typical box-shaped tetrameric association of identical monomers, containing six 4-stranded, antiparallel β-sheets that formed a propeller-like arrangement (Figure 3) , as previously described [29] . One calcium ion-binding site, conserved in all known influenza A and B virus NA loops [30, 31] , was observed in CIV NA. Calcium ions were previously shown to be critical for the thermostability and activity of influenza virus NAs, and this conserved metal site was proposed to be important in stabilizing a reactive conformation of the active site by otherwise flexible loops [30, 31] . Although CIV NA had 6 potential N-linked glycosylation sites at Asn86, Asn146, Asn200, Asn234, Asn313, and Asn402 in the final model, interpretable glycan density was only observed at Asn146, Asn200, and Asn234. Residue Asn146, which was situated on the membrane-distal surface close to the active site, was the only glycosylation site conserved among all other influenza A and B virus NAs [32, 33] .
Antigenic Characterization
HI assay demonstrated that the HA of A/canine/IL/12191/2015 virus was antigenically distinct from the HA of A(H3N8) CIVs previously isolated from dogs in the United States (Table 1) 
Pathogenicity in Mice
Unlike the majority of seasonal A(H1N1) and A(H3N2) viruses, most avian influenza viruses that can bind to α2,3-linked SA receptors, do not require prior adaptation to cause disease in mice [34] . Mice inoculated with 10 7.2 EID 50 of A/canine/ IL/12191/2015 virus displayed signs of infection, including severe weight loss, ruffled hair, and hunched posture. Except for 1 mouse, which was euthanized on day 4 after inoculation because of excessive weight loss, all of the animals recovered from the infection. Mice inoculated with 10 6.0 EID 50 of virus displayed transient weight loss (up to 9%) and no other signs of morbidity ( Figure 4A ). Groups of 3 mice were inoculated with serial dilutions of virus, and virus titers in lungs collected on day 3 after inoculation were used to calculate the 50% mouse infectious dose (MID 50 ). A/canine/IL/12191/2015 virus efficiently replicated in mouse lungs without prior adaptation. Detectable virus was observed in mice inoculated with doses >10 2 EID 50 , with the highest mean lung titer reaching 10 7.1 EID 50 /mL ( Figure 4B ). By 6 days after inoculation, mice inoculated with 10 7.2 EID 50 still had detectable virus in lungs (mean titer, 10 4.7 EID 50 /mL; data not shown). The MID 50 for the A(H3N2) CIV was 10 2.5 EID 50 .
Pathogenicity and Transmissibility in Ferrets
Ferrets inoculated with A/canine/IL/12191/2015 (H3N2) virus exhibited minimal weight loss (mean maximum, 3.1%) and an increase in body temperature (mean maximum, 1°C above baseline), and 2 of 3 infected ferrets exhibited mild lethargy (data not shown). None of the infected ferret had respiratory symptoms, such as sneezing or nasal discharge; however, ocular drainage was observed in 1 ferret on days 2-9 after inoculation.
A mean peak titer of 10 6.8 EID 50 /mL was found in nasal washes on day 1 after inoculation, and virus was cleared in all animals after 7 days ( Figure 5A ). All inoculated ferrets seroconverted (HI titers on day 27 after inoculation ranged from 320 to 640). At day 3 after inoculation, the virus was detected in the nasal turbinates and trachea of all inoculated ferrets, with average titers of 10 6.1 EID 50 /mL and 10 5.0 EID 50 /g of tissue, respectively ( Figure 5B ). Only 1 ferret had low levels of virus in the lungs (10 2.3 EID 50 /g). No virus was detected in rectal swab samples collected for up to 5 days after inoculation (data not shown), but an intestine sample from one of the ferrets had low levels of virus (10 2.7 EID 50 /g) on day 3 after inoculation. No virus was recovered from other extrapulmonary tissues, indicating that the canine A(H3N2) virus did not replicate systemically.
The fact that the CIV replicated very efficiently in the upper respiratory tract prompted us to evaluate the transmissibility of the virus in a direct-contact setting. The virus was transmitted in 1 of 3 pairs of cohoused animals within 3 days, as evidenced by a high virus load in nasal wash samples (10 6.3 EID 50 /mL; Figure 5A ) and seroconversion (HI titer on day 26 after contact, 640). The infected ferret displayed minimal weight loss (4.9%) and cleared the virus by day 9 after contact.
Replication in Calu-3 Cells
The human bronchial epithelial cell line (Calu-3), when grown on transwell inserts, resembles the human airway epithelium, as the cells form tight junctions to achieve transepithelial resistance [35] . Calu-3 cells were inoculated with 0.01 EID 50 (Figure 6 ). The A(H3N2) CIV replicated to similar titers as the seasonal A(H1N1) virus, reaching titers of ≥10 8.5 EID 50 /mL at 72 hours after inoculation, with no statistically significant differences between these viruses at any of the time points. In comparison, the seasonal A(H3N2) virus replicated less efficiently, reaching a mean average titer of 10 7.8 EID 50 /mL by 72 hours after inoculation; however, statistical significance between the seasonal A(H3N2) virus and CIV was only observed at the 24-hour time point.
DISCUSSION
The emergence of a new IAV in domestic animals represents a major public health risk because it provides the opportunity for zoonotic infections to occur in pet owners or persons with high levels of exposure to animals, potentially allowing novel IAVs to adapt to humans. High nucleotide similarity between the A(H3N2) CIVs isolated in the United States and those recently detected in South Korea and China is suggestive of a direct transmission event or introduction of this virus into the United States in early 2015. Generally, avian IAVs bind preferentially to cells expressing α2,3-linked SAs, while human IAVs preferentially bind to α2,6-linked SAs found on cells in the upper respiratory tract of humans [36] and ferrets [37] . Upper and lower respiratory tracts of dogs largely express α2,3-linked SA receptors [5, 38] , which likely facilitated the transmission of avian A(H3N2) influenza virus to dogs. The HA of the A/ canine/IL/12191/15 and A/canine/IL/11613/2015 viruses possessed the key residues (Gln226 and Gly228) necessary for α2,3-linked SA binding. Despite a few HA changes associated with mammalian adaptation (ie, Ser159Asn and Trp222Leu), these CIV HAs exhibited an avian receptor-binding preference. In addition, few markers of enhanced virulence were identified in the NA or internal proteins of this virus, indicating a lack of key mutations associated with increased pathogenicity for avian influenza viruses or adaptation to humans. Dogs infected with A(H3N2) CIVs typically develop signs of infection, including fever, lethargy, anorexia, nasal/ocular discharge, sneezing, and cough, and transmission of virus between dogs is efficient [39] . Interspecies transmission of A(H3N2) CIV has been demonstrated from dogs to cats, while transmission from dogs to ferrets was not observed in an experimental setting [40, 41] . Ferrets are naturally susceptible to human and avian influenza viruses and develop clinical signs similar to those seen in infected humans [34] . In this study, inoculated ferrets displayed minimal morbidity and no respiratory signs. A/canine/IL/12191/15 (H3N2) virus was not transmitted between all cohoused pairs of ferrets. It is possible that the lack of respiratory symptoms may have limited the quantity of virus expelled from the infected animals and contributed to the lack of efficient transmission [42, 43] . Despite the lack of overt respiratory symptoms, A/canine/ IL/12191/15 (H3N2) virus replicated most efficiently in the nasal turbinates and trachea, but low levels of virus were detected in the lungs. Previous studies of earlier strains of A(H3N2) CIVs (A/canine/Korea/01/2007 and A/canine/Korea/LBM412/2008) in ferrets demonstrated some differences in phenotypes as compared to the virus evaluated here. The 2007 A(H3N2) CIV replicated less efficiently in ferret nasal samples but was transmitted more frequently between paired ferrets in direct contact (2 of 3 pairs [40] and 3 of 3 pairs [44] ). The 2008 A(H3N2) CIV replicated more efficiently, was transmitted between animals in 3 of 6 ferret pairs, and caused substantially greater morbidity (15% weight loss) in inoculated ferrets [45] as compared to the 3.1% weight loss found using the A/canine/IL/12191/2015 virus reported here.
Antigenic differences between A(H3N8) and A(H3N2) CIVs reported in this study and the results of a recent study in mice [46] suggest that dogs previously vaccinated with A(H3N8) CIV vaccine may not be protected from infection or disease caused by the A(H3N2) CIV. Unless dogs are vaccinated with one of the currently available A(H3N2) CIV vaccines, the lack of immunity to the new A(H3N2) CIV may allow for additional opportunities for coinfection of this subtype with other influenza viruses. Serological analysis of dog serum samples showed that, in some cases, dogs tested positive for both canine A(H3N2) and 2009 pandemic A(H1N1) viruses, suggesting the possibility of coinfection with both viruses [47] . In fact, reassortants of A(H3N2) CIV and 2009 pandemic A(H1N1) viruses have been reported. An A(H3N1) virus with an HA gene from an A(H3N2) CIV and 7 genes homologous to 2009 pandemic A(H1N1) virus was isolated from dogs in South Korea [48] . This new reassortant virus was less pathogenic than classical CIV in experimentally infected dogs. An A(H3N2) CIV isolate containing a matrix gene from 2009 pandemic A(H1N1) virus (CIV/H3N2mv) was also isolated from dogs [49] . Ferrets and dogs experimentally infected with CIV/H3N2mv displayed signs of respiratory infection, and the virus had the capacity of efficient transmission between cohoused dogs and cohoused ferrets.
Overall, A/canine/IL/12191/2015 virus was capable of efficient replication in vitro in human airway epithelial cells and in the upper airways of ferrets and mice but was unable to be transmitted efficiently, likely owing to its avian receptor-binding properties. Receptor specificity is considered a major hurdle for influenza virus to adapt to humans and acquire the ability to sustain transmission in the population [50] . Evidence indicating that dogs can be infected with both canine and human influenza viruses raises the concern that a reassortant virus could emerge that is capable of infecting humans. The emergence of this new A(H3N2) CIV and the continued antigenic drift and reassortment [28] that it demonstrates in mammals warrants global surveillance and a better understanding of the pathogenesis and the potential for transmission of these viruses. Risk assessments such as these will improve our pandemic preparedness and will help mitigate the risk of zoonotic influenza virus infections and the threat to public health.
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